VEGFA and neoplasm: We observed that the tumor burden, measured for each individual mouse, was significantly lower in the VPA plus CHT or VPA plus CHT/anti-VEGF groups after one treatment cycle than in the other treatment groups (Fig. 5c and Supplementary Fig. 9c).